Kiora Pharmaceuticals(KPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KPRX Kiora Pharmaceuticals

已收盘 11-22 16:00:00 EST

3.37

+0.06

+1.78%

盘后3.37

+0.00+0.03%

18:57 EST

最高3.40	最低3.22	成交量6,950
今开3.31	昨收3.31	日振幅5.55%
总市值1,001万	流通市值447.99万	总股本297.05万
成交额2.31万	换手率0.52%	流通股本132.98万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KPRX","market":"US","secType":"STK","nameCN":"Kiora Pharmaceuticals","latestPrice":3.369,"timestamp":1732309200000,"preClose":3.31,"halted":0,"volume":6950,"hourTrading":{"tag":"盘后","latestPrice":3.37,"preClose":3.369,"latestTime":"18:57 EST","volume":410,"amount":1373.4066,"timestamp":1732319871186},"delay":0,"floatShares":1329752,"shares":2970545,"eps":1.692401,"marketStatus":"已收盘","marketStatusCode":5,"change":0.059,"latestTime":"11-22 16:00:00 EST","open":3.31,"high":3.4038,"low":3.22,"amount":23149.647275,"amplitude":0.055529,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.692401,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1438315200000,"adjPreClose":3.31,"postHourTrading":{"tag":"盘后","latestPrice":3.37,"preClose":3.369,"latestTime":"18:57 EST","volume":410,"amount":1373.4066,"timestamp":1732319871186},"volumeRatio":0.435322},"requestUrl":"/m/hq/s/KPRX/tweets","defaultTab":"tweets","newsList":[{"id":"2485782141","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘快速拉升7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485782141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485782141?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:51","pubTimestamp":1732117891,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日23时51分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速上涨7.12%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为1125.13%、842.68%、241.38%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为183.66%、121.32%、73.14%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112023513198e43c53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112023513198e43c53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","KPRX","BK4007","KPHCW"],"gpt_icon":0},{"id":"2483595258","title":"Kiora Pharmaceuticals, Inc.盘中异动 大幅跳水5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483595258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483595258?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:55","pubTimestamp":1731524139,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时55分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.24%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为541.07%、416.28%、149.94%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为131.00%、73.71%、71.97%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114025540abbe61ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114025540abbe61ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KPHCW","KPRX","KPHMW"],"gpt_icon":0},{"id":"2482739725","title":"Kiora Pharmaceuticals, Inc.盘中异动 大幅拉升6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482739725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482739725?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:37","pubTimestamp":1731339437,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日23时37分，Kiora Pharmaceuticals, Inc.股票出现异动，股价急速上涨6.10%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为505.78%、472.13%、139.44%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为123.43%、72.42%、40.91%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111233717a22d030a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111233717a22d030a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","KPHMW","BK4007","KPRX"],"gpt_icon":0},{"id":"2481260075","title":"Kiora Pharmaceuticals Inc 预计每股亏损 76 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481260075","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481260075?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:29","pubTimestamp":1730903371,"startTime":"0","endTime":"0","summary":"Kiora Pharmaceuticals Inc 预计每股亏损 76 美分 - 财报前瞻Kiora Pharmaceuticals Inc KPRX.OQ KPRX.O预计将在11月7日公布截至2024年9月30日的业绩(估计)，季度收入将有所增长。根据 LSEG 的数据，3 位分析师的平均预期显示，这家总部位于加利福尼亚州恩西尼塔斯的公司预计将实现营收 7,000 美元。LSEG 分析师对 Kiora Pharmaceuticals Inc 的平均预期是每股亏损 76 美分。华尔街对 Kiora Pharmaceuticals Inc 的 12 个月目标价中位数为 27.00 美元，高于其 3.52 美元的最新收盘价。11月6日 - 上一季度业绩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4T3MD2KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KPRX"],"gpt_icon":0},{"id":"2479783765","title":"Kiora Pharmaceuticals, Inc.盘中异动 大幅下挫5.45%报3.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479783765","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479783765?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:38","pubTimestamp":1730295513,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时38分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.45%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Calcimedica, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为2349.99%、124.56%、20.94%，振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为70.94%、25.49%、20.34%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021383398e3f684&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021383398e3f684&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KPHCW","KPRX","KPHMW"],"gpt_icon":0},{"id":"2479850283","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479850283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479850283?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:30","pubTimestamp":1730208643,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时30分，Kiora Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.94%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Lixte Biotechnology Holdings, Inc.涨幅较大，Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为501.77%、246.41%、119.70%，振幅较大的相关个股有Organovo Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Hepion Pharmaceuticals, Inc.，振幅分别为5.14%、4.54%、3.53%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213044ab7f13d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213044ab7f13d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","KPHCW","BK4007","KPRX"],"gpt_icon":0},{"id":"2478248484","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘急速拉升6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478248484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478248484?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:14","pubTimestamp":1730124844,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时14分，Kiora Pharmaceuticals, Inc.股票出现异动，股价急速拉升6.32%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Monte Rosa Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Tc Biopharm  Plc、Genprex, Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为620.42%、52.42%、51.83%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.，振幅分别为87.13%、84.14%、46.83%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822140498e3ed75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822140498e3ed75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","KPHCW","KPHMW","BK4007"],"gpt_icon":0},{"id":"2476177953","title":"Kiora Pharmaceuticals, Inc.盘中异动 股价大涨5.00%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476177953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476177953?lang=zh_cn&edition=full","pubTime":"2024-10-17 23:03","pubTimestamp":1729177404,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日23时03分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.00%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Molecular Templates, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Molecular Templates, Inc.、Notable Labs, Ltd.、180 Life Sciences Corp.较为活跃，换手率分别为1140.06%、413.88%、179.72%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为104.84%、103.23%、56.36%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101723032498e3d0a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101723032498e3d0a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","BK4007","KPRX","KPHMW"],"gpt_icon":0},{"id":"2476430689","title":"Kiora Pharmaceuticals, Inc.盘中异动 快速拉升5.00%报3.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476430689","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476430689?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:58","pubTimestamp":1729094315,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时58分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.00%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，180 Life Sciences Corp.、Quoin Pharmaceuticals Ltd、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6314.82%、1099.11%、939.89%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Quoin Pharmaceuticals Ltd，振幅分别为633.55%、279.52%、196.43%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623583698e3cd22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623583698e3cd22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","BK4007","KPRX","KPHCW"],"gpt_icon":0},{"id":"2472614259","title":"Kiora Pharmaceuticals, Inc.盘中异动 大幅下跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472614259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472614259?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:32","pubTimestamp":1727965979,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时32分，Kiora Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.78%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Elevai Labs, Inc.、Theriva Biologics, Inc.、Verrica制药涨幅较大，Theriva Biologics, Inc.、Aditxt, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为4269.59%、1033.10%、786.53%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为142.28%、59.86%、43.48%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003223300a1de2779&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003223300a1de2779&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","BK4007","KPHCW","KPRX"],"gpt_icon":0},{"id":"2472036356","title":"Kiora Pharmaceuticals, Inc.盘中异动 大幅上涨6.71%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472036356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472036356?lang=zh_cn&edition=full","pubTime":"2024-10-01 04:00","pubTimestamp":1727726445,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日04时00分，Kiora Pharmaceuticals, Inc.股票出现异动，股价大幅上涨6.71%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Capricor Therapeutics, Inc.、Kezar Life Sciences, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Aditxt, Inc.、Seelos Therapeutics, Inc.、Onconetix, Inc.较为活跃，换手率分别为284.08%、71.98%、66.60%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Tc Biopharm  Plc C/Wts 10/02/2028 、Capricor Therapeutics, Inc.，振幅分别为87.30%、85.25%、58.09%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100104004598e39ea3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100104004598e39ea3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","KPHCW","BK4007","KPHMW"],"gpt_icon":0},{"id":"2470419526","title":"Kiora Pharmaceuticals, Inc.盘中异动 急速下挫6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470419526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470419526?lang=zh_cn&edition=full","pubTime":"2024-09-25 00:04","pubTimestamp":1727193891,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日00时04分，Kiora Pharmaceuticals, Inc.股票出现波动，股价大幅跳水6.04%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Seelos Therapeutics, Inc.、Wave Life Sciences Ltd.、Capricor Therapeutics, Inc.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃，换手率分别为4070.92%、184.34%、135.37%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Onconetix, Inc.，振幅分别为101.84%、58.52%、45.08%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925000452ab65aaf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925000452ab65aaf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","KPHCW","BK4007","KPHMW"],"gpt_icon":0},{"id":"2461835843","title":"Kiora Pharmaceuticals, Inc.盘中异动 股价大涨6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461835843","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461835843?lang=zh_cn&edition=full","pubTime":"2024-08-21 02:49","pubTimestamp":1724179780,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日02时49分，Kiora Pharmaceuticals, Inc.股票出现异动，股价急速拉升6.19%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Cingulate Inc.较为活跃，换手率分别为3599.50%、2545.13%、922.72%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、泰坦制药、Biomotion Sciences C/Wts Exp 15/08/2029 ，振幅分别为274.86%、128.68%、78.89%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821024941a1d53fd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240821024941a1d53fd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","BK4007","KPRX","KPHCW"],"gpt_icon":0},{"id":"2460688140","title":"Kiora Pharmaceuticals, Inc.盘中异动 下午盘股价大涨6.39%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460688140","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460688140?lang=zh_cn&edition=full","pubTime":"2024-08-20 02:18","pubTimestamp":1724091501,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日02时18分，Kiora Pharmaceuticals, Inc.股票出现异动，股价快速拉升6.39%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.29%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为8763.34%、3710.11%、1246.94%，振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为405.90%、220.18%、198.02%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002182298e3567b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002182298e3567b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","BK4007","KPHMW","KPHCW"],"gpt_icon":0},{"id":"2460736370","title":"Kiora Pharmaceuticals, Inc.2024财年第二财季实现净利润-2.22百万美元，同比增加14.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460736370","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460736370?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910676,"startTime":"0","endTime":"0","summary":"8月18日，Kiora Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-2.22百万美元，同比增加14.94%；其中营业收入为20000.00美元，每股基本收益为-0.53美元。从资产负债表来看，Kiora Pharmaceuticals, Inc.总负债7.71百万美元，其中短期债务42126.00美元，资产负债比为5.30，流动比率为19.18。机构评级：截至2024年8月18日，当前有3家机构对Kiora Pharmaceuticals, Inc.目标价做出预测，其中目标均价为30.33美元，其中最低目标价为10.00美元，最高目标价为54.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180007149f34081b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180007149f34081b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPRX","KPHCW","KPHMW"],"gpt_icon":0},{"id":"2459530212","title":"Kiora Pharmaceuticals, Inc.盘中异动 快速拉升5.54%报3.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459530212","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459530212?lang=zh_cn&edition=full","pubTime":"2024-08-16 21:31","pubTimestamp":1723815100,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日21时31分，Kiora Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.54%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Cingulate Inc.、Seelos Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2580.86%、1054.75%、114.27%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Forte Biosciences, Inc.，振幅分别为100.53%、31.46%、9.45%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408162131409f3165fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408162131409f3165fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KPHCW","KPRX","KPHMW"],"gpt_icon":0},{"id":"2459135443","title":"Kiora Pharmaceuticals, Inc.盘中异动 股价大跌5.86%报3.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459135443","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459135443?lang=zh_cn&edition=full","pubTime":"2024-08-14 02:43","pubTimestamp":1723574593,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日02时43分，Kiora Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.86%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.47%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029、Orgenesis Inc.涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为150.15%、137.67%、40.96%，振幅较大的相关个股有冠科美博、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Os Therapies Incorporated，振幅分别为78.40%、49.54%、42.38%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814024314af97451c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814024314af97451c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHMW","BK4007","KPHCW","KPRX"],"gpt_icon":0},{"id":"2458989055","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘快速下跌6.87%报3.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458989055","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458989055?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:02","pubTimestamp":1723471337,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时02分，Kiora Pharmaceuticals, Inc.股票出现波动，股价大幅跳水6.87%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Revance Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Oragenics Inc.、Revance Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为57.21%、33.62%、12.35%，振幅较大的相关个股有Oragenics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc.，振幅分别为40.71%、26.33%、23.72%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220218aefe6c4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220218aefe6c4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KPRX","KPHMW","KPHCW"],"gpt_icon":0},{"id":"2458597496","title":"Kiora Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458597496","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458597496?lang=zh_cn&edition=full","pubTime":"2024-08-09 22:48","pubTimestamp":1723214926,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日22时48分，Kiora Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.83%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.90%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Azitra Inc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为73.90%、51.61%、31.49%，振幅较大的相关个股有Cingulate Inc.、Azitra Inc、An2 Therapeutics, Inc.，振幅分别为35.31%、33.82%、22.48%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080922484696825784&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080922484696825784&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","KPHMW","KPRX","BK4007"],"gpt_icon":0},{"id":"2457316075","title":"Kiora Pharmaceuticals, Inc.盘中异动 快速上涨5.30%报3.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457316075","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457316075?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:33","pubTimestamp":1723123990,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时33分，Kiora Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.30%。Kiora Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Anew Medical, Inc.涨幅较大，Anew Medical, Inc.、Conduit Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为183.30%、179.27%、40.39%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Generation Bio Co.，振幅分别为27.33%、17.43%、14.41%。Kiora Pharmaceuticals, Inc.公司简介：Kiora Pharmaceuticals Inc 是一家临床阶段的生物技术公司，致力于开发和商业化用于治疗孤儿性视网膜疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213310958900c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213310958900c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPHCW","KPHMW","BK4007","KPRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kiorapharma.com","stockEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0516},{"period":"3month","weight":-0.122},{"period":"6month","weight":-0.3263},{"period":"1year","weight":-0.3042},{"period":"ytd","weight":-0.296}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kiora Pharmaceuticals, Inc.于2004年12月26日以EyeGate Pharmaceuticals, Inc.的名义成立为特拉华州公司，并于2021年11月8日起更名为Kiora Pharmaceuticals, Inc.。该公司是一家临床阶段的专业制药公司专注于开发和商业化用于治疗眼疾的疗法和药物输送。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.108303},{"month":2,"riseRate":0.555556,"avgChangeRate":0.161552},{"month":3,"riseRate":0.111111,"avgChangeRate":-0.134209},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000799},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.082098},{"month":6,"riseRate":0.111111,"avgChangeRate":-0.176545},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.16599},{"month":8,"riseRate":0.2,"avgChangeRate":-0.130787},{"month":9,"riseRate":0.4,"avgChangeRate":-0.016834},{"month":10,"riseRate":0.3,"avgChangeRate":-0.018985},{"month":11,"riseRate":0.4,"avgChangeRate":0.09493},{"month":12,"riseRate":0.333333,"avgChangeRate":0.057855}],"exchange":"NASDAQ","name":"Kiora Pharmaceuticals","nameEN":"Kiora Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kiora Pharmaceuticals(KPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kiora Pharmaceuticals(KPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kiora Pharmaceuticals,KPRX,Kiora Pharmaceuticals股票,Kiora Pharmaceuticals股票老虎,Kiora Pharmaceuticals股票老虎国际,Kiora Pharmaceuticals行情,Kiora Pharmaceuticals股票行情,Kiora Pharmaceuticals股价,Kiora Pharmaceuticals股市,Kiora Pharmaceuticals股票价格,Kiora Pharmaceuticals股票交易,Kiora Pharmaceuticals股票购买,Kiora Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kiora Pharmaceuticals(KPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kiora Pharmaceuticals(KPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况